WST stock

West Pharmaceutical Services Inc (WST) earnings · P/E 49, rev $3.07B

These earnings events as JSON? API free 100/day

West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.

This WST earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported WST revenue for 2025-12-31 was $3.07B. Net income was $493.7M. Revenue was up 6.3% from 2024-12-31 to 2025-12-31. WST currently screens at market cap $15.97B and trailing P/E 49.0.

When the next WST 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was up 6.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.

Not investment advice. Full WST research stays on the stock page; the tape stays on the quote page.

WST earnings FAQ

What are WST's latest revenue and net income?

Latest cached West Pharmaceutical Services Inc (WST) revenue for Dec 31, 2025 was $3.07B. Net income was $493.7M. Statements: https://lician.com/financials/wst

What is WST's latest diluted EPS?

Latest cached West Pharmaceutical Services Inc (WST) diluted EPS for Dec 31, 2025 was $6.79.

What period does the latest WST earnings print cover?

The latest cached West Pharmaceutical Services Inc (WST) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

How did WST revenue change from the prior cached period?

Cached West Pharmaceutical Services Inc (WST) revenue was up 6.3% from $2.89B (Dec 31, 2024) to $3.07B (Dec 31, 2025). Statements: https://lician.com/financials/wst

What is WST's P/E ratio?

West Pharmaceutical Services Inc (WST) trailing P/E is 49.0 on the latest cached fundamentals snapshot.

Where are WST earnings listed?

Cached earnings facts for West Pharmaceutical Services Inc (WST) are listed at https://lician.com/earnings/wst. Statements: https://lician.com/financials/wst

Not investment advice.

Full WST analysis